Long-Term Efficacy of Daclizumab HYP in Relapsing-Remitting Multiple Sclerosis: 3 Year Results from the SELECTED Extension Study (P7.226)
暂无分享,去创建一个
X. Montalban | E. Radue | R. Gold | E. Havrdová | G. Giovannoni | K. Selmaj | T. Sprenger | M. Beatty | Yaoshi Wu | Randy R. Robinson | D. Stefoski | G. Ozen